Legal Representation
Attorney
Peter T. Wakiyama
USPTO Deadlines
Next Deadline
1098 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-07-31)
Due Date
July 31, 2028
Grace Period Ends
January 31, 2029
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 15, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| May 15, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| May 15, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 23, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jul 31, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 31, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 23, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 22, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 22, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 20, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 20, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jun 20, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 20, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 5, 2018 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Feb 5, 2018 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Feb 5, 2018 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Feb 5, 2018 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jan 22, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 22, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 20, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 20, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 25, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 25, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 5, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 15, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 15, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 15, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 14, 2016 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 14, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 14, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 15, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 15, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 15, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 27, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 038
Providing access to a searchable database of data and information relating to drug safety, drug interactions, and clinical reaction behavior of patients to certain medication and treatment methods, all for scientific research purposes; providing access to a searchable database of data and information relating to drug safety, drug interactions, and clinical reaction behavior of patients to certain medication and treatment methods, all for medical treatment purposes
First Use Anywhere:
Jun 3, 2016
First Use in Commerce:
Jun 3, 2016
Classification
International Classes
038
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MOLECULAR HEALTH"